HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caterina Finizia Selected Research

Laryngeal Neoplasms (Laryngeal Cancer)

3/2022Effect of voice rehabilitation following radiotherapy for laryngeal cancer - a 3-year follow-up of a randomised controlled trial.
11/2020Cost-effectiveness analysis of voice rehabilitation for patients with laryngeal cancer: a randomized controlled study.
4/2020Well-Being of Caregivers of Patients with Laryngeal Cancer Treated by Radiotherapy.
11/2019Letter to editor: Misleading conclusions in the recently published study by Taito et al. "Voice rehabilitation for laryngeal cancer after radiotherapy: a systematic review and meta-analysis".
10/2018Community listeners' perceptions of voice function post-radiotherapy for laryngeal cancer.
12/2017Effects of voice rehabilitation after radiotherapy for laryngeal cancer: a longitudinal study.
1/2017Voice Range Profile and Health-related Quality of Life Measurements Following Voice Rehabilitation After Radiotherapy; a Randomized Controlled Study.
1/2017Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being.
6/2016A prospective longitudinal study of voice characteristics and health-related quality of life outcomes following laryngeal cancer treatment with radiotherapy.
1/2016Voice rehabilitation for laryngeal cancer patients: Functional outcomes and patient perceptions.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caterina Finizia Research Topics

Disease

16Laryngeal Neoplasms (Laryngeal Cancer)
03/2022 - 07/2009
11Head and Neck Neoplasms (Head and Neck Cancer)
12/2021 - 11/2015
7Trismus (Lockjaw)
01/2022 - 06/2010
7Neoplasms (Cancer)
12/2021 - 06/2010
6Deglutition Disorders (Dysphagia)
01/2022 - 12/2015
3Gastroesophageal Reflux (GERD)
01/2009 - 01/2002
2Pain (Aches)
01/2022 - 10/2019
2Fatigue
10/2019 - 01/2014
2Heartburn (Pyrosis)
06/2005 - 01/2003
1Otosclerosis
06/2022
1Asthenia
03/2022
1Overweight
12/2021
1Weight Loss (Weight Reduction)
12/2021
1COVID-19
01/2021
1Temporomandibular Joint Disorders (Temporomandibular Joint Disorder)
10/2019
1Xerostomia
02/2019
1Carcinoma in Situ
01/2016
1Airway Obstruction (Choking)
12/2015
1Eosinophilic Esophagitis
12/2015
1Communication Disorders (Communication Disorder)
08/2014
1Hoarseness
01/2014
1Rhinitis
05/2012
1Olfaction Disorders (Cacosmia)
03/2006
1Vomiting
01/2003
1Nausea
01/2003

Drug/Important Bio-Agent (IBA)

54-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
04/2020 - 08/2013
4AcidsIBA
01/2009 - 01/2003
2Cisapride (Propulsid)FDA Link
10/2003 - 01/2002
2Serotonin 5-HT4 Receptor AgonistsIBA
10/2003 - 01/2002
1SteroidsIBA
12/2015
1AntigensIBA
12/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2012
1AllergensIBA
05/2012
1mosaprideIBA
10/2003
1Serotonin 5-HT3 Receptor AntagonistsIBA
10/2003
1compound 20IBA
01/2002

Therapy/Procedure

25Radiotherapy
03/2022 - 07/2009
4Aftercare (After-Treatment)
01/2021 - 06/2010
2Exercise Therapy (Therapy, Exercise)
07/2021 - 12/2015
2Drug Therapy (Chemotherapy)
07/2021 - 04/2018
2Laryngectomy
05/2014 - 03/2006
1Hearing Aids (Hearing Aid)
06/2022
1Chemoradiotherapy
01/2022
1Enteral Nutrition (Feeding, Tube)
12/2021
1Personal Protective Equipment
01/2021
1Radiotherapy Dosage
06/2010